Clinical trial

DEPO-Trigger Trial: GnRH Agonist DEPOt TRIGGER for Final Oocyte Maturation

NCT04616729

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2022-11-01

PhasePHASE1 / PHASE2

Study timeline

Study start (actual)2022-11-01Date precision: day

Registry last updated2023-05-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancer Femaleunresolved

Interventions

Triptorelin 3.75 MG InjectionDRUG · verified · RxNorm: triptorelin 3.75 MG Injection

Transvaginal oocyte retrievalPROCEDURE

Triptorelin InjectionDRUG · verified · RxNorm: triptorelin Injection

Sponsors & collaborators

Universitair Ziekenhuis Brussellead sponsor

Universitaire Ziekenhuizen KU Leuvencollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04616729 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.